ArticleNature cancer2022

Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment.

Chiara Falcomatà et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.